NIB Holdings (ASX: NHF) eyes improved profitability through risk pool refreshment and pricing

NIB Holdings Limited (ASX: NHF)operates as a provider of health insurance services. Its offerings include health and medical insurance coverage tailored for both Australian and New Zealand residents, as well as health insurance options designed specifically for international students and workers within Australia.

Team Kalkine | 13 May 2024| Read Time : 10 Mins

Two ASX Listed Stocks Giving Bullish Indications – PIQ, BB1

Proteomics International Laboratories Ltd (<a href="https://kalkine.com.au/company/asx-piq/" target="_blank" rel="noopener">ASX:PIQ</a>) is a medical technology company based in Australia. The company offers bio-analytical services and predictive diagnostics, specializing in proteomics—the study of protein structure and function. Their goal is to create and market …

Team Kalkine | 09 May 2024| Read Time : 10 Mins

Eagers Automotive (ASX: APE) eyes additional AUD 1bn in revenue in FY24

Eagers Automotive Limited (ASX: APE)is in the business of selling both new and pre-owned motor vehicles, distributing and selling parts, accessories, and car care products, offering vehicle repair and servicing, providing extended warranties, and managing property and investments.

Team Kalkine | 09 May 2024| Read Time : 10 Mins

Cedar Woods Properties (ASX: CWP) expects NPAT of AUD 36-39mn in FY24

Cedar Woods Properties Limited (ASX: CWP)is an ASX-listed firm with focus on property investment and development ventures within Australia. The company actively participates in the development of residential, commercial, and retail properties across Western Australia, South Australia, Victoria, and Queensland.

Team Kalkine | 07 May 2024| Read Time : 10 Mins

Credit Corp Group (ASX: CCP) expects NPAT of AUD 80-90M in FY24

Credit Corp Group Limited (ASX: CCP)is an ASX-listed financial services company which is engaged in debt purchasing, collection and consumer lending. The Australia-based firm has presence across New Zealand, Australia and the USA markets.

Team Kalkine | 06 May 2024| Read Time : 10 Mins

Neuren Pharmaceuticals (ASX: NEU) expects royalties and milestone payments to drive earnings in FY24

Neuren Pharmaceuticals Limited (ASX: NEU)focuses on creating novel drug treatments for neurological disorders. In the financial year 2023 ended 31 December 2023 (FY23), licensing revenue of NEU increased by 1488% to AUD 231.9 million, while profit after tax jumped 78450% to AUD 157.1 million.

Team Kalkine | 01 May 2024| Read Time : 10 Mins

Revenue of Renascor Resources (ASX: RNU) jumps 214% in 1HFY24. What lies ahead?

Renascor Resources Limited (ASX: RNU)focuses on mineral exploration, development, and evaluation endeavors within Australia. Its primary project is the Siviour Graphite and Battery Anode Material Project. Additionally, the company has a variety of prospects in its portfolio for the development of copper, gold, rare …

Team Kalkine | 30 Apr 2024| Read Time : 10 Mins